Athanor Capital’s Bausch Health BHC Stock Holding History

Athanor Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,461	Closed	-$319K	–	548
2020 Q2	$319K	Buy	+17,461	New	+$308K	0.02%	401

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Athanor Capital's BHC Position: Q3 2020 in Review

Athanor Capital sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 17,461 shares — an estimated $319K sold.

Athanor Capital first reported a position in BHC in Q2 2020 and held it in 1 quarter. The position peaked at $319K in Q2 2020. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

Athanor Capital reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
Athanor Capital sold 17,461 Bausch Health shares in Q3 2020, an estimated $319K.
Athanor Capital first reported a position in Bausch Health in Q2 2020 and held it in 1 quarter.
Athanor Capital's Bausch Health position peaked at $319K in Q2 2020.
324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Athanor Capital's 13F filing for Q3 2020, filed 16 Nov 2020.